Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma: Defining the pancreatic pancer epigenome

Cancer Biology and Therapy

Volumn 7, Issue 7, 2008, Pages 1157-1159

  Corn, Paul ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CpG island; Genome wide; MCA; Methylation; Pancreatic cancer

Indexed keywords

CA 19-9 ANTIGEN;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DNA METHYLATION; GENE MUTATION; HUMAN; METASTASIS; NOTE; ORGANOGENESIS; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION;

EID: 47949126882     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.7.6616     Document Type: Note

References (38)

1. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol 2008;3:157-88.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008 Mar; 58(2):71-96.
3. Vulfovich M, Rocha-Lima C. Novel advances in pancreatic cancer treatment. Expert Rev Anticancer Ther 2008 Jun; 8(6):993-1002.
4. Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol 2007 Aug; 34(4):295-302.
5. Denlinger CS, Cohen SJ. Progress in the development of prognostic and predictive markers for gastrointestinal malignancies. Curr Treat Options Oncol 2007 Oct; 8(5):339-51.
6. Jimeno A, Hidalgo M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 2006 Apr; 5(4):787-96.
7. Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer 2003 Jan 7; 2:7.
8. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A. Pancreatic carcinogenesis. Pancreatol 2008; 8(2):110-25.
9. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000 Apr 1; 60(7):1835-9.
10. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003 Nov 20; 349(21):2042-54.
11. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002 Mar; 2(3):210-9.
12. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001 Apr 15; 61(8):3225-9.
13. Sato N, Ueki T, Fukushima N, Iacobuzio-Donahue CA, Yeo CJ, Cameron JL, et al. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterol 2002 Jul; 123(1):365-72.
14. Fukushima N, Sato N, Ueki T, Rosty C, Walter KM, Wilentz RE, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelialneoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002 May; 160(5):1573-81.
15. Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol 2008 Mar; 21(3):238-44.
16. Fukushima N, Walter KM, Uek T, Sato N, Matsubayashi H, Cameron JL, et al. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2003 Jan; 2(1):78-83.
17. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006 Jan 15; 66(2):1208-17.
18. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006 Feb; 6(2):107-16.
19. Gius D, Bradbury CM, Sun L, Awwad RT, Huang L, Smart DD, et al. The epigenome as a molecular marker and target. Cancer 2005 Nov 1; 104(9):1789-93.
20. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007 Feb 23; 128(4):683-92.
21. Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, et al. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 2008 Apr 29; 7(7).
22. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, et al. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res 2001 Dec 1; 61(23):8540-6.
23. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006 Oct 13; 314(5797):268-74.
24. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007 Nov 16;3 18(5853):1108-13.
25. Chan TA, Glockner S, Yi JM, Chen W, Van NL, Cope L, et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 2008 May 27; 5(5):e114.
26. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A 1998 Sep 29; 95(20):11891-6.
27. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A 1999 Oct 26; 96(22):12754-9.
28. Holst CR, Nuovo GJ, Esteller M, Chew K, Baylin SB, Herman JG, et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 2003 Apr 1; 63(7):1596-601.
29. Licchesi JD, Westra WH, Hooker CM, Herman JG. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 2008 May 1; 14(9):2570-8.
30. Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007 Feb; 39(2):237-42.
31. Ohm JE, Baylin SB. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation? Cell Cycle 2007 May 2; 6(9):1040-3.
32. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, et al. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 2007 Feb; 39(2):232-6.
33. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, Spizzo G, Marth C, et al. Epigenetic stem cell signature in cancer. Nat Genet 2007 Feb; 39(2):157-8.
34. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007 Feb 1; 67(3):1030-7.
35. Hirose H, Nakahara T, Zhang QM, Yonei S, Miyakoshi J. Static magnetic field with a strong magnetic field gradient (41.7 T/m) induces c-Jun expression in HL-60 cells. In Vitro Cell Dev Biol Anin 2003; 39:348-52.
36. Lin H, Blank M, Rossol-Haseroth K, Goodman R. Regulating genes with electromagnetic response elements. J Cell Biochem 2001; 81:143-8.
37. Zhang QM, Tokiwa M, Doi T, Nakahara T, Chang PW, Nakamura N, Hori M, Miyakoshi J, Yonei S. Strong static magnetic field and the induction of mutations through elevated production of reactive oxygen species in Escherichia coli soxR. Int J Radiat Biol 2003; 79:281-6.
38. McCann J, Dietrich F, Rafferty C. The genotoxic potential of electric and magnetic fields: an update. Mutat Res 1998; 411:45-86.